These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11229686)

  • 1. The dystrophy of Duchenne.
    Jay V; Vajsar J
    Lancet; 2001 Feb; 357(9255):550-2. PubMed ID: 11229686
    [No Abstract]   [Full Text] [Related]  

  • 2. The Duchenne de Boulogne-Meryon controversy and pseudohypertrophic muscular dystrophy.
    Bach JR
    J Hist Med Allied Sci; 2000 Apr; 55(2):158-78. PubMed ID: 10820967
    [No Abstract]   [Full Text] [Related]  

  • 3. Duchenne muscular dystrophy: hopes for the sesquicentenary.
    Byrne E; Kornberg AJ; Kapsa R
    Med J Aust; 2003 Nov; 179(9):463-4. PubMed ID: 14583075
    [No Abstract]   [Full Text] [Related]  

  • 4. Images in clinical medicine. Muscular dystrophy.
    Servais L; Aubert G
    N Engl J Med; 2014 Dec; 371(23):e35. PubMed ID: 25470715
    [No Abstract]   [Full Text] [Related]  

  • 5. Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy.
    Dubowitz V
    Neuromuscul Disord; 2006 Dec; 16(12):865-6. PubMed ID: 17118656
    [No Abstract]   [Full Text] [Related]  

  • 6. Duchenne muscular dystrophy or Meryon's disease.
    Emery A
    Lancet; 2001 May; 357(9267):1529. PubMed ID: 11383539
    [No Abstract]   [Full Text] [Related]  

  • 7. Early observations on duchenne-meryon muscular dystrophy.
    Pearce JM
    Eur Neurol; 2005; 54(1):46-8. PubMed ID: 16103677
    [No Abstract]   [Full Text] [Related]  

  • 8. Early observations on muscular dystrophy: Gowers' textbook revisited.
    Pascuzzi RM
    Semin Neurol; 1999; 19(1):87-92. PubMed ID: 10711992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased cerebral perfusion in Duchenne muscular dystrophy patients.
    Doorenweerd N; Dumas EM; Ghariq E; Schmid S; Straathof CS; Roest AA; Wokke BH; van Zwet EW; Webb AG; Hendriksen JG; van Buchem MA; Verschuuren JJ; Asllani I; Niks EH; van Osch MJ; Kan HE
    Neuromuscul Disord; 2017 Jan; 27(1):29-37. PubMed ID: 27927595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [One hundred books which built up neurology (31)--William Richard Gowers "Pseudo-hypertrophic muscular paralysis. A clinical lecture" (1879)].
    Sakuta M
    Brain Nerve; 2009 Jul; 61(7):880-1. PubMed ID: 19618867
    [No Abstract]   [Full Text] [Related]  

  • 11. Lockhart Clarke (1817-1880): his role in the early history of muscular dystrophy.
    Emery AE; Emery ML
    Neuromuscul Disord; 2000 Oct; 10(7):530-3. PubMed ID: 10996787
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
    Wein N; Alfano L; Flanigan KM
    Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duchenne and Becker muscular dystrophies.
    Flanigan KM
    Neurol Clin; 2014 Aug; 32(3):671-88, viii. PubMed ID: 25037084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origins and early descriptions of "Duchenne muscular dystrophy".
    Tyler KL
    Muscle Nerve; 2003 Oct; 28(4):402-22. PubMed ID: 14506712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G. B. A. Duchenne de Boulogne (1806-1875).
    Rondot P
    J Neurol; 2005 Jul; 252(7):866-7. PubMed ID: 15999235
    [No Abstract]   [Full Text] [Related]  

  • 16. 50 Years Ago in The Journal of Pediatrics: An Assessment of the Creatine Kinase Test in the Detection of Carriers of Duchenne Muscular Dystrophy.
    Cardon MW
    J Pediatr; 2017 Jul; 186():63. PubMed ID: 28648283
    [No Abstract]   [Full Text] [Related]  

  • 17. A possible role of dystrophin in neuronal excitability: a review of the current literature.
    Hendriksen RG; Hoogland G; Schipper S; Hendriksen JG; Vles JS; Aalbers MW
    Neurosci Biobehav Rev; 2015 Apr; 51():255-62. PubMed ID: 25677308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the dystrophin-ATP connection: How half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology.
    Timpani CA; Hayes A; Rybalka E
    Med Hypotheses; 2015 Dec; 85(6):1021-33. PubMed ID: 26365249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillaume-Benjamin Duchenne: a miserable life dedicated to science.
    Maranhão-Filho P; Vincent M
    Arq Neuropsiquiatr; 2019 Jul; 77(6):442-444. PubMed ID: 31314848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Discovery of Therapies for Duchenne Muscular Dystrophy.
    Blat Y; Blat S
    J Biomol Screen; 2015 Dec; 20(10):1189-203. PubMed ID: 25975656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.